Target Binding and Structural Analysis
A degrader can bind its target protein and recruitment partner yet still fail to drive productive protein degradation. Weak ternary complex formation, unfavorable protein orientation, restricted linker geometry, and poor intracellular target engagement can all limit its performance. BOC Sciences provides target binding and structural analysis services to help pharmaceutical and biotechnology researchers understand how degraders recognize proteins, assemble complexes, and create productive interactions. We combine biophysical binding measurements, ternary complex characterization, structural biology, interface mapping, and cell-based assays to explain binding behavior and guide degrader optimization. Our analysis strategies can be adapted to PROTACs, molecular glues, lysosome-targeting degraders, and peptide- or oligonucleotide-based systems.
Request a Consultation Explore ServicesServices
BOC Sciences Target Binding and Structural Analysis Services for TPD Development
Our services address eight related questions, from whether each binding partner is engaged to whether the resulting complex has a suitable architecture in cells. The assay combination is selected according to the degrader modality, protein properties, available material, and research objective.
Target Protein-Degrader Binary Binding Analysis
We determine whether a degrader retains binding to its protein of interest after the target-binding ligand has been modified or linked to another component. Our binding affinity measurement services support screening and quantitative comparison of target-binding candidates.
- Affinity and kinetics: SPR and BLI measure KD, kon, and koff where the assay supports reliable kinetic fitting.
- Orthogonal confirmation: ITC, MST, or fluorescence polarization can assess solution binding, thermodynamics, or competitive displacement.
- Design comparison: Compare free ligands, full degraders, and linker variants to identify affinity losses caused by conjugation.
E3 Ligase-Degrader Binary Binding Analysis
For E3-dependent degraders, we assess binding to the selected ligase substrate-recognition component or relevant protein complex. This helps determine whether the recruiter remains accessible when the full degrader is assembled and informs subsequent E3 ligase ligand design decisions.
- Recruiter binding: Compare affinity toward CRBN-, VHL-, or other project-relevant recruitment systems.
- Linker interference: Test whether attachment position or steric bulk changes binding kinetics or apparent affinity.
- Reference controls: Evaluate parent ligands and nonbinding controls under matched assay conditions.
Ternary Complex Formation and Stability Analysis
Binary binding alone does not establish that the target, degrader, and recruitment partner can assemble together. Our PROTAC ternary complex assays investigate complex formation, dissociation, and concentration-dependent behavior to distinguish productive recruitment from isolated binding events.
- Complex assembly: SPR, BLI, proximity assays, and selected native-state measurements assess formation under defined conditions.
- Stability and kinetics: Examine dissociation behavior and apparent complex residence time to compare degrader candidates.
- Concentration response: Investigate nonproductive binary saturation and possible hook-effect behavior at elevated degrader concentrations.
Ternary Complex Cooperativity Analysis
Cooperativity describes how binding of one protein partner changes the affinity of a degrader for the second partner. We compare binary and ternary binding measurements from a defined binding step to help explain why degraders with similar individual affinities can show different recruitment behavior.
- Cooperativity factor: Calculate α = KD, binary / KD, ternary using comparable measurements for the same binding interaction.
- Interpretation: α > 1 indicates positive cooperativity, α = 1 indicates no cooperativity, and α < 1 indicates negative cooperativity.
- Candidate ranking: Combine cooperativity with dissociation kinetics and degradation data rather than treating α as a stand-alone predictor of activity.
Binary and Ternary Complex Structural Analysis
Structural information reveals how a degrader occupies binding pockets and positions its protein partners. BOC Sciences offers protein-ligand structural analysis using methods selected for protein size, sample stability, and structural feasibility.
- Experimental structures: X-ray crystallography and cryo-EM may resolve binding orientations, protein contacts, and ternary complex architecture.
- Solution-state evidence: NMR and complementary analyses can investigate ligand contacts and conformational behavior.
- Structure-guided design: Assess linker exit vectors, steric clashes, and protein orientation; achievable structural detail depends on the system.
Binding Interface and Conformational Analysis
When full complex structures are unavailable or the proteins remain flexible, we investigate interaction surfaces and binding-induced changes using experimental constraints and computational models. Our molecular dynamics simulation capabilities can help examine alternative poses and linker conformations.
- Interface mapping: HDX-MS, cross-linking mass spectrometry, or targeted mutagenesis can identify regions involved in complex formation.
- Conformational assessment: Evaluate changes in protein flexibility and ligand positioning upon binary or ternary binding.
- Model refinement: Use experimental observations to constrain docking hypotheses and identify structures for follow-up testing.
Cellular Target Engagement Analysis
Affinity measured with isolated proteins may not translate directly into cellular engagement. We evaluate whether degraders access and interact with their intended targets in relevant cell models, taking exposure, target abundance, and assay context into account.
- Cell-based binding: Tracer-competition BRET approaches may provide apparent engagement or occupancy measurements when suitable tracers are available.
- Orthogonal evidence: Cellular thermal stability analysis and protease-protection assays can provide complementary evidence of target engagement through changes in protein stability or proteolytic susceptibility.
- Data interpretation: Distinguish cellular EC50 or apparent occupancy from a purified-protein KD.
Cellular Ternary Complex Formation Analysis
We investigate whether degrader-induced proximity occurs in cells, where protein localization, binding-partner expression, and intracellular availability influence the outcome. This analysis connects purified-protein interaction data with biological context.
- Live-cell proximity: BRET- or FRET-based systems can track concentration-dependent or time-dependent recruitment.
- Complex confirmation: Co-immunoprecipitation and appropriate negative controls provide complementary interaction evidence.
- Mechanistic context: Compare proximity signals with target depletion and pathway readouts; proximity alone does not prove degradation.
Need Help Understanding Your Degrader's Binding Behavior?
Tell us which proteins, degrader candidates, and binding questions you are working with. BOC Sciences can recommend a focused assay panel or an integrated binding and structural analysis program.
TPD Modalities
Binding and Structural Analysis for Different TPD Modalities
Different targeted protein degradation strategies recruit different partners. We tailor the binding models, structural experiments, and cellular confirmation steps to the actual degradation mechanism rather than applying an E3 ligase assay to every modality.
PROTACs and Other Bifunctional Degraders
For E3-recruiting bifunctional degraders, we examine two binary interactions and the resulting three-component assembly. The goal is to determine whether ligand and linker selection permits a suitable target-E3 orientation.
- Binary recognition: Measure target and recruitment-partner binding.
- Ternary behavior: Assess cooperativity, formation, dissociation, and possible hook effects.
- Complex architecture: Map protein contacts and linker-dependent geometry.
Molecular Glue Degraders
Unlike a conventional bifunctional degrader, a molecular glue may create or stabilize a protein-protein interaction without strong measurable binding to both proteins separately. We investigate induced recruitment and the surfaces responsible for neo-substrate recognition, supporting molecular glue degrader development.
- Induced interaction: Compare protein association with and without the small molecule.
- Interface changes: Use native-state, proximity, structural, or HDX-based analysis where feasible.
- Selectivity questions: Compare recruitment of intended and related protein substrates.
Lysosome-Targeting Degraders
For lysosome-targeting chimeras, the key recruitment partner is often a cell-surface trafficking receptor rather than an E3 ligase. We assess target recognition, receptor engagement, and the molecular geometry relevant to co-recruitment, complementing LYTAC development strategies.
- Dual recognition: Confirm extracellular target and trafficking-receptor binding.
- Surface interactions: Study binding competition, receptor accessibility, and complex formation.
- Cellular context: Pair binding evidence with receptor-mediated uptake and lysosomal delivery studies.
Peptide- and Oligonucleotide-Based Degraders
Peptide and oligonucleotide binders can recognize proteins through sequences, folded structures, or extended interaction surfaces. We adapt binding and structural measurements to the binder architecture, including concepts used in peptide-based PROTAC development and oligonucleotide-based degrader development.
- Sequence-dependent recognition: Assess specificity and binding strength under suitable solution conditions.
- Structural organization: Examine folding, attachment sites, and steric accessibility.
- Format-specific recruitment: Select ternary or cellular assays according to the actual degradation partner.
Which TPD Modality Are You Developing?
Share your degrader format, target, and recruitment mechanism. We can build a binding and structural analysis plan around the biology of your system.
Value
Why Target Binding and Structural Analysis Matters for TPD Development?
Confirm Target and E3 Ligase Binding
Determine whether both recognition elements still bind after degrader assembly. Separating target and recruiter binding helps identify a weak ligand or a linker attachment that interferes with engagement before more complex experiments begin.
Understand Ternary Complex Formation and Stability
Explain why strong binary binding does not always produce efficient degradation. Complex formation, cooperativity, and dissociation kinetics reveal recruitment differences that a single affinity measurement may miss.
Reveal Binding Interfaces and Structural Interactions
Identify contacts between the target, degrader, and recruited protein. Structural and interface data can reveal steric clashes, conformational flexibility, and accessible attachment positions for further compound design.
Guide Degrader Design and Lead Optimization
Connect binding and structural observations with cellular recruitment and target depletion. This provides practical evidence for selecting among linker variants, recruiter choices, and promising degrader candidates.
Workflow
Our Target Binding and Structural Analysis Workflow
01
Project Assessment and Analysis Strategy Design
We review the target protein, degrader architecture, recruitment partner, existing activity data, and unresolved questions. The study plan defines decision criteria, controls, suitable biophysical assays, and structural options, with attention to whether the system is E3-dependent or uses an alternative degradation pathway.
02
Protein and Degrader Sample Preparation
We review target and partner protein construct design, folding, stability, and sample quality. Where needed, custom protein expression and purification can be integrated. Parent ligands, complete degraders, controls, and matched protein preparations are organized for consistent measurements.
03
Binary Binding Affinity and Kinetics Analysis
SPR or BLI is used where suitable to quantify target and recruitment-partner binding. ITC, MST, or competition formats can provide orthogonal information. We compare binding strength and kinetics across candidate compounds, while checking assay interference, nonspecific binding, and protein integrity.
04
Ternary Complex Formation and Cooperativity Analysis
Selected compounds proceed to three-component interaction studies. We examine concentration-dependent assembly, stability, dissociation behavior, and cooperativity using appropriate biophysical or proximity-based assays. The resulting dataset helps identify candidates whose binding interactions favor complex recruitment.
05
Structural Characterization and Binding Interface Analysis
For selected leads, we pursue crystallographic, cryo-EM, NMR, or interface-mapping approaches according to feasibility. Experimental observations can inform protein structure modeling and pose comparison to evaluate linker geometry, protein contacts, and conformational flexibility.
06
Cellular Binding Validation and Structure-Guided Optimization
We use suitable cellular engagement or proximity assays to examine whether the interactions observed with purified proteins persist in a biological setting. The final interpretation links binding, complex formation, structure, and available degradation data into candidate rankings and testable optimization recommendations.
At Which Analysis Stage Do You Need Support?
Whether you need initial binding measurements, a ternary complex study, structural interpretation, or cellular confirmation, BOC Sciences can support the relevant stage of your degrader research.
Applications
Applications of Target Binding and Structural Analysis in TPD Development
Target-Binding Ligand Screening and Prioritization
Compare target-binding ligands and assembled degraders using consistent affinity and kinetic measurements. Identify candidates that retain target engagement after modification and select compounds for more detailed recruitment analysis.
Ternary Complex Formation and Stability Optimization
Compare linker variants or recruitment partners when candidates show similar binary affinity but different degradation results. Integrate complex assembly, cooperativity, and dissociation kinetics to guide the next optimization round.
Degrader Selectivity and Binding Mechanism Investigation
Assess interactions with related targets or potential alternative protein partners. Pair binding measurements with PROTAC selectivity evaluation when distinguishing selective recruitment from unintended degradation is an important project question.
Structure-Guided Degrader Lead Optimization
Translate binding-site and complex-geometry findings into testable chemistry choices. Structural data can support linker attachment-site selection and design, linker-length comparisons, and improved orientation of the recruited proteins.
Have a Specific TPD Research Application in Mind?
Whether your goal is ligand screening, complex optimization, selectivity investigation, or structure-guided design, BOC Sciences can tailor the analysis to your target and research objective.
Why Us
Why Choose BOC Sciences for Target Binding and Structural Analysis?
Comprehensive Biophysical and Structural Analysis Platforms
Our research services connect real-time binding assays, solution-state measurements, structural studies, and computational interpretation. Scientists can choose methods based on the information required rather than relying on a single readout.
Integrated Binary Binding and Ternary Complex Characterization
We connect separate ligand-protein measurements with complex formation, cooperativity, and dissociation behavior. This helps clients distinguish weak recognition from unfavorable molecular recruitment.
Customized Assay Strategies for Different Degrader Modalities
Our study designs account for whether the recruitment partner is an E3 ligase, lysosomal trafficking receptor, or another biological component. Protein construct selection, controls, and cell models are matched to the modality.
Structure-Guided Data Interpretation and Degrader Optimization
We interpret binding and structure data alongside the available cellular response to identify plausible changes in linker geometry, protein contact surfaces, or recruitment strategy for the next design cycle.
Case Study
Client Success Stories: Target Binding and Structural Analysis
Project Background
A European team developed a CRBN-recruiting PROTAC series targeting STAT3 in solid tumor research. STAT3 dimerizes through its SH2 domain and drives proliferative signaling in the client's tumor models. The goal was to rank lead compounds by ternary complex formation, not binary affinity.
Technical Challenges
STAT3 dimerization complicates ternary design; the assembly may be monomeric, dimeric or higher-order with different SPR responses. PROTACs bound both partners but ternary stability did not track degradation, requiring a structural rationale for linker geometry.
BOC Sciences Solutions
- Binary binding baseline: KD values were measured by SPR and ITC for each warhead analog against STAT3 SH2 monomer and the pre-formed SH2 dimer, with matched counter-screens against CRBN alone.
- Sandwich SPR for ternary detection: STAT3 SH2 dimer was immobilized on the sensor surface and CRBN was flowed with and without each PROTAC, so that de novo cooperative ternary complex formation could be distinguished from residual binary binding.
- Cooperativity (alpha) ranking: alpha values were calculated from matched binary and ternary KD datasets across linker exit vectors and stereochemistry, and ranked against the cellular DC50 to confirm the cooperativity-to-degradation relationship.
- Cryo-EM of ternary complex: a single-particle reconstruction was obtained for the top-ranked PROTAC, providing an experimental structural model of the STAT3-CRBN ternary arrangement that guided the next design cycle.
Project Outcomes
BOC Sciences identified the linker exit vector maximizing cooperativity and resolved a STAT3-CRBN structural model. The alpha panel produced a ranked short list, and a CRBN-based PROTAC targeting STAT3 strategy was confirmed as the most tractable path forward.
Project Background
A US team characterized a molecular glue recruiting GSPT1 to a CRBN-containing E3 ligase complex. GSPT1 degradation was reproducible across cancer lines, but binary binding to either partner was weak by SPR and ITC. The goal was to confirm induced cooperative binding.
Technical Challenges
Binary readouts disagreed with cellular potency, and a glue-induced ternary complex needed confirmation. Native-state characterization confirmed stoichiometry, and an experimental structure of the complete ternary complex would support the next round.
BOC Sciences Solutions
- Native MS for ternary detection: native ESI-MS and mass photometry were used to detect a glue-dependent GSPT1-CRBN complex with matched negative controls, confirming a 1:1:1 ternary stoichiometry at micromolar concentrations.
- HDX-MS interface mapping: differential HDX-MS compared binary, ternary and ligate-modified samples to map the induced contact surface between GSPT1 and CRBN, and identified a protected patch that appeared only with both CRBN and the glue.
- Cross-linking MS for residue contacts: cross-linking MS placed GSPT1 and CRBN lysines within cross-link distance of identified contact residues, anchoring the induced interface to specific side chains.
- Cryo-EM of ternary assembly: a low-resolution single-particle reconstruction was obtained for the complete GSPT1-CRBN-glue ternary complex, providing the first experimental structural model for the program.
Project Outcomes
BOC Sciences confirmed GSPT1 degradation is driven by an induced cooperative GSPT1-CRBN interaction and provided a complete ternary structural model. Interface mapping identified three hotspots explaining cooperative behavior, and a CRBN-based molecular glue targeting GSPT1 strategy was prioritized over inhibitor optimization.
Frequently Asked Questions (FAQ)
Why Is Strong Binary Binding Insufficient for Protein Degradation?
Strong binary binding does not necessarily lead to efficient targeted protein degradation. For bifunctional degraders such as PROTACs, productive degradation depends on interactions with both the target protein and an E3 ligase, followed by the formation of a ternary complex with a suitable molecular orientation. Even when both binding ligands show strong affinity, an unfavorable linker length, attachment position, or protein interface may prevent productive complex assembly. Cellular permeability and E3 ligase availability can also influence degradation activity. Therefore, researchers should evaluate binary binding kinetics, ternary complex cooperativity, structural interactions, and cellular degradation together rather than relying on binding affinity alone.
How Does Ternary Complex Cooperativity Influence Degrader Performance?
Ternary complex cooperativity describes how the recruitment of one protein influences the binding of another protein within a degrader-induced complex. Positive cooperativity indicates that the interactions formed within the ternary complex favor its assembly, whereas negative cooperativity may suggest unfavorable contacts or steric interference. However, stronger cooperativity does not always guarantee better degradation performance. The orientation of the target protein, complex dissociation kinetics, and accessibility of residues involved in ubiquitination also influence productive degradation. Researchers commonly use techniques such as SPR and ITC to characterize cooperativity and compare these results with cellular degradation data to understand differences between degrader candidates.
Which Methods Reveal Degrader Binding Sites and Structural Interactions?
Several complementary techniques can help identify degrader binding sites and characterize protein interactions. X-ray crystallography can reveal detailed binding orientations and interacting residues when suitable crystals are available. Cryo-EM can provide structural information for selected larger protein complexes and help investigate their conformational states. HDX-MS can identify regions affected by ligand binding and detect changes in protein dynamics. Cross-linking mass spectrometry, site-directed mutagenesis, and molecular modeling can provide additional evidence about binding interfaces. The most appropriate combination depends on protein characteristics, complex stability, and the research objective. Integrating structural and biophysical data helps researchers understand binding mechanisms and identify opportunities for structure-guided degrader optimization.
What Information Should Clients Provide Before Binding Analysis?
To develop an appropriate binding and structural analysis strategy, clients can provide information about their target protein, E3 ligase, degrader structure, and available experimental results. Existing binding affinity measurements, degradation data, or preliminary structural information can help define the research priorities. BOC Sciences can assess protein sample requirements, degrader characteristics, and suitable analytical methods based on the project's development stage. Our scientists can design studies covering binary binding, ternary complex formation, and structural characterization according to the specific research questions. For projects without an established analytical workflow, we can also help determine the starting assays, experimental controls, and key evaluation parameters needed to support subsequent investigations.
Can BOC Sciences Investigate Degraders With Weak Cellular Activity?
Yes. Some targeted protein degraders demonstrate measurable binding in biochemical assays but fail to produce the expected degradation response in cellular models. BOC Sciences can develop a stepwise investigation strategy to help identify potential causes. Depending on the available data, our services can evaluate binary binding to the target protein and E3 ligase, characterize ternary complex formation and cooperativity, and examine structural interactions that may influence productive complex assembly. Cellular target engagement studies can provide further information about differences between biochemical and cellular activity. By integrating these results, our scientists can help clients investigate binding-related limitations, unfavorable complex geometry, or cellular engagement challenges and identify potential directions for degrader redesign and lead optimization.
Testimonials
Client Testimonials on Target Binding and Structural Analysis
From Binding Data to Candidate Selection
"We had eleven PROTAC analogs that all looked reasonable on paper and one cellular assay that we could not reproduce. The cooperativity panel from BOC Sciences cut through the noise in a way we had not been able to do internally. Within two weeks we had α values, ternary half-lives and a ranked short list."
- Dr. Jimenez, Senior Scientist, a mid-size pharmaceutical company in Germany
Understanding Ternary Complex Behavior
"Our molecular glue degrades the substrate cleanly in cells but we could not see a binary interaction by SPR, and we were stuck. The native MS and HDX-MS work from BOC Sciences showed us, for the first time, that the binding is genuinely induced and cooperative. That single insight changed how the whole chemistry team thinks about the next design cycle."
- Ms. Sanders, Principal Investigator, a translational research institute in the United Kingdom
How Structural Insights Guided Linker Optimization
"The cryo-EM map of our ternary complex was the moment the program clicked. BOC Sciences did not just hand us a density map; they handed us a short list of three specific atoms to change and a prediction of how cooperativity would move. Two of those predictions held, and one of them is now our lead compound."
- Dr. Henderson, Director of Medicinal Chemistry, a biotech in Japan
A Collaborative Approach to Complex Binding Challenges
"What we appreciated most was the willingness to push back on the experimental design when the original plan was not going to answer our question. The team redesigned the cooperativity panel twice as the data came in, and we always knew what we were paying for and why. The final report is now the standard we hold other CRO partners to."
- Mr. Brooks, Head of Structural Biology, a biopharmaceutical company in Sweden
* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
BOC Sciences Support
Please contact us with any specific requirements and we will get back to you as soon as possible.
